Table 1

Sample information

Sample*

Age (years)

Sex

28S/18S ratio

GAPDH 5'/3' ratio

Expressed probe sets (%)§

Diagnosis

Epilepsy

Types of seizures


HA1

70

M

1.2

0.445

50.6

-

-

-

HA3

45

M

1.6

0.637

49.7

-

-

-

HA4

45

M

1.2

0.507

49.4

-

-

-

HA5

54

F

1.6

0.712

51.7

-

-

-

HR1

45

M

1.1

0.520

50.5

Anaplastisches Oligo WHO III

Yes

Simple partial

HR2

39

F

1.3

0.700

50.2

Glioblastoma

Yes

Simple and complex partial, GM

HR3

61

M

1.6

0.774

53.8

Glioblastoma

Yes

Simple and complex partial

HR4

51

F

1.6

0.697

49.5

Ammon's horn sclerosis

Yes

Simple and complex partial, GM

HR5

13

M

1.4

0.778

47.1

Ganglioglioma

Yes

Complex partial

HR6

83

F

1.3

0.817

50.0

Atpisches Meningeom Grad II

No

-

CA1

45

M

1.4

0.870

51.0

-

-

-

CA2

45

M

1.4

0.841

51.4

-

-

-

CA3

48

M

1.5

0.865

53.2

-

-

-

CA5

70

M

1.4

0.669

47.2

-

-

-

CA6

82

F

1.7

0.690

47.7

-

-

-

CA7

67

M

NA

0.810

49.5

-

-

-

CR1

35

F

1.2

0.741

45.9

Focal cortical dysplasia

Yes

Complex partial, GM

CR2

31

F

1.3

0.741

39.5

Focal cortical dysplasia

Yes

Simple partial

CR3

9

F

NA

0.607

45.6

Focal cortical dysplasia

Yes

Complex partial

CR4

37

M

NA

0.674

43.7

Focal cortical dysplasia

Yes

Complex partial

CR5

35

F

NA

0.737

48.8

Focal cortical dysplasia

Yes

Complex partial, GM

CR6

31

F

NA

0.674

43.1

Focal cortical dysplasia

Yes

Simple partial


*Sample names: position one = brain region (H, hippocampus; C, cortex); position two = sample source (A, autopsy; R, resection); position three = individual. Ribosomal RNA bands ratio was measured using Agilent 2100 Bionalyzer system. GAPDH ratio was measured using probes to 5' and 3' of the transcript on Affymetrix® array. §Expressed probesets were defined based on detection p < 0.05. F, female; GM, grand mal; M, male; NA, not applicable.

Franz et al. Genome Biology 2005 6:R112   doi:10.1186/gb-2005-6-13-r112

Open Data